It has been found that specific deletions of MSH6, BTG1, and NR3C1 have been related to resistance to thiopurines, alkylators (MSH6) and GCs (BTG1 and NR3C1) in pediatric B-ALL (56). Here, MSH6 is linked to precursor B-cell acute lymphoblastic leukemia.